Total Funding
49
51
Total FundingSeed raised
Growth Score 49 in past quarter
-7 pts
Heat Score 51 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58864
PredxBio is a computational pathology company developing AI tools to analyze whole slide image pathology samples based on spatial analytics.
- Chakra Chennubhotla: Chief Executive OfficerPast Role: PredxBio, Chief of AI, COO and Co-Founder
- Akif Tosun: CTOPast Role: PredxBio, VP of Products & Chief of Staff
About the Company
PredxBio is a computational pathology company that develops AI tools to analyze whole slide image pathology samples based on spatial analytics. The company helps clinicians and researchers accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. Its AI-based
tool automatically recognizes and classifies regions of interest (ROIs) in H&E-stained and immunohistochemistry slides to help pathologists and biopharma companies use personalized spatial intelligence to make clinical decisions and make therapeutic strategies.
